REG - Cambridge Nutrition. - Appointment of Chief Executive Officer

Cambridge Nutritional SciencesAnnouncement

01/04/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250401:nRSA0168Da&default-theme=true

RNS Number : 0168D  Cambridge Nutritional Sciences PLC  01 April 2025

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

 

Appointment of Chief Executive Officer

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition ("the Company") is pleased to announce that
Mr. James Cooper, currently serving as Interim Chief Executive Officer, has
been offered the permanent role as the Chief Executive Officer of the Company,
effective 31(st) March 2025.

Following the resignation of the prior CEO Mr. Jag Grewal and his subsequent
departure from the Board in August 2024, James Cooper, who previously held the
position of Chief Operating Officer, was appointed as Interim Chief Executive
Officer. Since his appointment, James Cooper has impressed the Board with his
strong operational leadership, building a solid foundation to deliver on our
strategic objectives to deliver profitable growth for Shareholders over the
coming years

Cally Rand, Chair of CNSL, comments:

 

"I'm delighted that James has agreed to take on the role permanently and I
look forward to seeing the changes he will bring forward to strengthen the
business".

 

The Board looks forward to James' continued leadership and the positive impact
he will have on the Company's future growth and success.

For further information, please contact:

 

Contacts:

 

 Cambridge Nutritional Sciences plc                         www.cnsplc.com (http://www.cnsplc.com)
 Carolyn Rand, Non-Executive Chair
 James Cooper, Chief Executive Officer

 Cavendish Capital Markets Limited                        Tel: 020 7220 0500
 Geoff Nash / Edward Whiley (Corporate Finance)
 Nigel Birks / Harriet Ward (ECM)

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAWPUQGWUPAGMG